National Academies Press: OpenBook
« Previous: Front Matter
Suggested Citation:"Summary." Institute of Medicine. 2012. Breast Cancer and the Environment: A Life Course Approach. Washington, DC: The National Academies Press. doi: 10.17226/13263.
×

Summary

Abstract: Breast cancer accounts for substantial morbidity among women in the United States, with an estimated 230,480 new cases of invasive disease in 2011. Susan G. Komen for the Cure®and its Scientific Advisory Board commissioned a study by the Institute of Medicine (IOM) to assess the current evidence on the contribution of environmental exposures, alone or in combination with genetic factors, to the risk of developing breast cancer; review the challenges in investigating potential environmental contributions; explore evidence-based actions that women might take to reduce the risk of breast cancer; and recommend research directions.

“Environment” was broadly defined to encompass all factors that are not directly inherited through DNA, and a qualitative review examined current evidence on selected factors that illustrate various environmental agents and conditions that may be more amenable to modification. For some of these factors, epidemiologic studies consistently support associations with increased risk for breast cancer (e.g., ionizing radiation, combination hormone therapy, greater postmenopausal weight) or reduced risk (e.g., more physical activity). For many other factors, however, the epidemiologic evidence is more limited, contradictory, or absent. Evidence from animal or mechanistic studies sometimes adds support to the epidemiologic evidence or suggests biologic plausibility when human evidence is lacking for a particular factor.

Knowledge about the complexity of breast cancer and its relation to environmental exposures continues to grow, but researchers face many challenges. To move toward greater opportunities for prevention, more needs to be learned about the biologic significance of the life stages at which

Suggested Citation:"Summary." Institute of Medicine. 2012. Breast Cancer and the Environment: A Life Course Approach. Washington, DC: The National Academies Press. doi: 10.17226/13263.
×

environmental risk factors are encountered; optimal approaches to assessing exposures, designing and analyzing epidemiologic studies, and integrating analysis of genetic and environmental influences; the possible combined effects of a multitude of low-level chemical exposures; and interpretation of findings from studies in animals and in vitro systems.

Although many questions remain regarding the contributions of environmental factors to breast cancer risk, evidence suggests that women may have some opportunities to reduce their risk of breast cancer through personal actions: avoiding unnecessary medical radiation throughout life, avoiding use of some forms of postmenopausal hormone therapy, avoiding smoking, limiting alcohol consumption, increasing physical activity, and, for postmenopausal breast cancer, minimizing weight gain. The potential risk reductions for any individual woman will vary and may be modest, but the impact of these actions could be important at a population level. In many cases, however, lack of robust data on environmental agents’ effects on human breast cancer risk, especially during different life stages, and some sense of the trade-offs involved, are major challenges for identifying evidence-based actions that could be taken at the individual or societal level to reduce breast cancer risk.

Recommendations for research include applying a life course perspective and a transdisciplinary approach to studies of breast cancer, developing new and better tools for epidemiologic research and carcinogenicity testing of chemicals and other substances, developing effective preventive interventions, developing better approaches to modeling breast cancer risks, and improving communication about breast cancer risks to health care providers, policy makers, and the public.

Breast cancer has long been the most common invasive noncutaneous cancer among women in the United States, accounting for an estimated 230,480 new cases in 2011.1 After lung cancer, it is the second most common cause of women’s cancer mortality, with about 39,520 deaths expected in 2011. In 2011, there were also approximately 2,140 new cases of breast cancer and 450 breast cancer deaths among men in the United States.

Knowledge about the complexity of breast cancer continues to grow: the characterization of multiple tumor subtypes; the likelihood that critical events in the origins of breast cancer can occur very early in life; the variety of pathways through which breast cancer risks may be shaped; the likely contribution to breast cancer of some fundamental biological processes;

_________________

1Approximately 57,650 noninvasive (in situ) breast tumors will also have been diagnosed in 2011.

Suggested Citation:"Summary." Institute of Medicine. 2012. Breast Cancer and the Environment: A Life Course Approach. Washington, DC: The National Academies Press. doi: 10.17226/13263.
×

and the potential significance of the timing and combinations of environmental exposures in determining their effect on risks for different types of breast cancer. This growing knowledge is helping to stimulate a transition in breast cancer research, with new ideas influencing the design and analysis of epidemiologic studies, experimental studies in animals, and mechanistic studies of breast cancer biology. As this work elucidates how endogenous and exogenous factors may influence the development of breast cancer, new opportunities for prevention may emerge.2

Susan G. Komen for the Cure and its Scientific Advisory Board requested that the Institute of Medicine (IOM) review the current evidence on environmental risk factors for breast cancer, consider gene–environment interactions in breast cancer, explore evidence-based actions that might reduce the risk of breast cancer, and recommend research in these areas. The Statement of Task for the study appears in Box S-1.

The committee interpreted “environment” broadly, to encompass all factors that are not directly inherited through DNA. As a result, this definition includes elements that range from the cellular to the societal: the physiologic and developmental course of an individual, by-products of innate metabolic processes that can be modulated by external stressors, diet and other ingested substances, physical activity, microbial agents, physical and chemical agents encountered in any setting, medical treatments and interventions, social factors, and cultural practices. With the potentially vast scope of the study task, the committee focused on areas that it considered to be the most significant and the most pertinent to its charge. In particular, the study focused primarily on breast cancer in women and on the initial occurrence of a tumor, not recurrence. The committee took into account the changes in the breast over a woman’s life and the potential for the timing of exposures to influence risks they may pose for breast cancer. The committee did not address practices in the diagnosis and treatment of breast cancer or policies or practices for breast cancer screening.

REVIEWING EVIDENCE ON CERTAIN ENVIRONMENTAL FACTORS

The committee explored the available evidence concerning breast cancer risks associated with a necessarily limited selection of specific factors that illustrate a variety of environmental agents and conditions (see Box S-2 and Chapter 3). The committee drew on evidence reviews by authoritative bodies, especially the International Agency for Research on Cancer (IARC) and the World Cancer Research Fund (WCRF) International, supplemented

_________________

2The term “breast cancer” is used in this report to refer to disease in humans, and “mammary cancer” or “mammary tumor” to refer to disease in animals.

Suggested Citation:"Summary." Institute of Medicine. 2012. Breast Cancer and the Environment: A Life Course Approach. Washington, DC: The National Academies Press. doi: 10.17226/13263.
×

BOX S-1
Study Charge

In response to a request from Susan G. Komen for the Cure®, the Institute of Medicine will assemble a committee to:

1. Review the evidentiary standards for identifying and measuring cancer risk factors;

2. Review and assess the strength of the science base regarding the relationship between breast cancer and the environment;

3. Consider the potential interaction between genetic and environmental risk factors;

4. Consider potential evidence-based actions that women could take to reduce their risk of breast cancer;

5. Review the methodological challenges involved in conducting research on breast cancer and the environment; and

6. Develop recommendations for future research in this area.

In addition to reviewing the published literature, the committee will seek input from stakeholders, in part by organizing and conducting a public workshop to examine issues related to the current status of evidentiary standards and the science base, research methods, and promising areas of research. The workshop will focus on the challenges involved in the design, conduct, and interpretation of research on breast cancer and the environment. The committee will generate a technical report with conclusions and recommendations, as well as a summary report for the lay public.

by reviews and original research reports in the peer-reviewed literature. The committee qualitatively reviewed relevant literature, without a formal systematic review or quantitative analysis (e.g., meta-analysis) or the intensive weighing of evidence undertaken by IARC or WCRF. Several familiar topics, such as diet and most dietary components, received less attention because of ongoing systematic review by other groups. Providing a review of a complete set of environmental agents and conditions was not feasible. Of the large number of environmental factors with potential but uncertain impact on breast cancer, the committee reviewed only a selected number that illustrated particular types of challenges in assessment.

The aim was to characterize the available evidence on whether the selected environmental factors are associated with breast cancer, and to identify areas of substantial uncertainty. Evidence from epidemiologic studies carried the greatest weight in identifying risk factors. Evidence from experimental studies in animals or in vitro systems, especially in the absence

Suggested Citation:"Summary." Institute of Medicine. 2012. Breast Cancer and the Environment: A Life Course Approach. Washington, DC: The National Academies Press. doi: 10.17226/13263.
×

BOX S-2
Environmental Factors Included in the Committee’s Evidence Review
a

Exogenous hormones

• Hormone therapy: androgens, estrogens, combined estrogen–progestin

• Oral contraceptives

Body fatness and abdominal fat

Adult weight gain

Physical activity

Dietary factors

• Alcohol consumption

• Dietary supplements and vitamins

• Zeranol and zearalenone

Tobacco smoke

• Active smoking

• Passive smoking

Radiation

• Ionizing (including X-rays and gamma rays)

• Non-ionizing (extremely low frequency electric and magnetic fields [ELF-EMF])

Shift work

Metals

• Aluminum

• Arsenic

• Cadmium

• Iron

• Lead

• Mercury

Consumer products and constituents

• Alkylphenols

• Bisphenol A (BPA)

• Nail products

• Hair dyes

• Parabens

• Perfluorinated compounds (PFOA, PFOS)

• Phthalates

• Polybrominated diphenyl ethers (PBDEs; flame retardants)

Industrial chemicals

• Benzene

• 1,3-Butadiene

• PCBs

• Ethylene oxide

• Vinyl chloride

Pesticides

• DDT/DDE

• Dieldrin and aldrin

• Atrazine and S-chloro triazine herbicides (atrazine)

Polycyclic aromatic hydrocarbons (PAHs)

Dioxins

images

aThe committee reviewed a selected set of factors for illustration; the chemicals were not chosen to be representative of any class. Some epidemiologic, or animal data relevant to mammary tumorigenesis or breast cancer are available for numerous other chemicals.

Suggested Citation:"Summary." Institute of Medicine. 2012. Breast Cancer and the Environment: A Life Course Approach. Washington, DC: The National Academies Press. doi: 10.17226/13263.
×

of human data, was the basis for noting that some factors may present a hazard, and thus potentially contribute to breast cancer risk, alone or in combination with other factors, depending on the nature of an exposure (e.g., amount, timing). A hazard has the potential to cause an adverse effect under certain conditions of exposure; a risk is the probability that the adverse effect will occur in a person or a population as a result of an exposure to a hazard.

Among the environmental factors reviewed, those most clearly associated with increased breast cancer risk in epidemiologic studies are use of combination hormone therapy products, current use of oral contraceptives, exposure to ionizing radiation, overweight and obesity among postmenopausal women, and alcohol consumption. Greater physical activity is associated with decreased risk. Some major reviews have concluded that the evidence on active smoking is consistent with a causal association with breast cancer, and other large-scale reviews describe the evidence as limited. For several other factors reviewed by the committee, the available epidemiologic evidence is less strong but suggests a possible association with increased risk: passive smoking, shift work involving night work, benzene, 1,3-butadiene, and ethylene oxide. For some of the reviewed factors (e.g., bisphenol A or BPA), animal or mechanistic data suggest biological plausibility as a hazard. A few factors, such as non-ionizing radiation and personal use of hair dyes, have not been associated with breast cancer risk in multiple, well-designed human studies. For several other factors, evidence was too limited or inconsistent to reach a conclusion (e.g., nail products, phthalates). In all cases, these conclusions are based on assessments of the currently available evidence; it is always possible for new evidence to point to different conclusions.

As the committee considered the current state of knowledge, it sees a need for research on the etiology of breast cancer to do more to incorporate new understanding of breast development over the life course, recent advances in elucidating the molecular biology of tumorigenesis, and the challenges of assessing the potential impact of a multitude of low-level chemical exposures. A more integrative approach to breast cancer research may accelerate progress in understanding the role that environmental factors may have in breast cancer.

CHALLENGES IN STUDYING BREAST CANCER AND THE ENVIRONMENT

Trying to determine which environmental exposures may influence rates of breast cancer poses substantial challenges. The biology of breast development and the origins and progression of breast cancer are not fully understood, and much research in the past lacked tools to differentiate

Suggested Citation:"Summary." Institute of Medicine. 2012. Breast Cancer and the Environment: A Life Course Approach. Washington, DC: The National Academies Press. doi: 10.17226/13263.
×

among types of breast cancer. Also, a focus primarily on exposures during adulthood, as in past research, may miss critical windows during early life in which some environmental exposures may influence risk for breast cancer later in life.

Tracing multiple and potentially interacting causes of breast cancer will be difficult. Some risk factors may have very weak effects or effects in only a small portion of the population, making their contribution to risk hard to detect. People are exposed to a complex and changing mix of environmental agents over the course of a lifetime; discerning the effects of an individual agent, or knowing whether the components of the mixture may interact to influence the development of disease, is not straightforward. Moreover, many of these agents have never been studied in ways that could indicate whether they might be relevant to breast cancer. Several challenges appear especially formidable.

Assessing Human Exposure

It can be difficult to identify and measure exposures because few tools and opportunities are available for doing so directly, especially if relevant exposures occurred well in the past or the timing of such exposures is unclear. Many studies must base estimates of exposure on error-prone indicators such as self-reports of past product use or proxies for exposure, such as holding a particular type of job or living in a particular location at a particular time. Even when it is possible to detect evidence of exposure from biological samples (e.g., blood or urine), single measurements are rarely sufficient to establish the duration and levels of past exposure, and few studies have the benefit of multiple samples from the same study participant for comparisons over time. Determining the number of samples needed and interpreting comparisons among them requires a good understanding of the biological processes that influence variation in the production and retention of these biomarkers of exposure.

Conducting Epidemiologic Studies

Experimental studies in humans (i.e., controlled clinical trials), in which host factors and exposures can be carefully controlled, would provide the strongest evidence of causal associations, but they are rarely an option in studying causes of breast cancer because study participants should not be exposed to substances suspected of causing harm. As a result, researchers must generally rely on observational studies that depend on either collecting retrospective information about critical exposures and life events or conducting large prospective studies of extended duration. A few large cohorts of adult women have provided a valuable base for investigating breast

Suggested Citation:"Summary." Institute of Medicine. 2012. Breast Cancer and the Environment: A Life Course Approach. Washington, DC: The National Academies Press. doi: 10.17226/13263.
×

cancer risk factors. But because it is likely that breast cancer diagnosed in older adult women is influenced by exposures at various stages of life, ideal prospective investigations would follow a study population throughout life. Such studies are very costly and logistically difficult to implement. Reliable predictors of increased risk for breast cancer that could be assessed at much younger ages (e.g., during adolescence) would greatly aid investigation of the influence of early-life exposures, but current understanding is limited to risk factors such as age at menarche and at first full-term pregnancy. An additional complication is that for some environmental pollutants, low-level exposures are so widespread and co-occur with low levels of numerous other possible contributors that it is difficult to identify an unexposed comparison group or adequately control for other exposures.

Identifying Genetic Influences

Only a few genetic markers of substantially increased risk are well established (e.g., BRCA1 and BRCA2 mutations), and these are rare in the general population. Studies suggest that other, more common mutations and polymorphisms may also be associated with breast cancer, but have a much smaller influence on risk. The multitude of potential associations and the relatively small differences in risk mean that studies must be very large to detect statistically significant effects, and efforts to replicate findings are often not successful because false positive rates are high in small studies. Gene–environment interactions for breast cancer risk have been shown in several epidemiologic studies for high alcohol intake combined with polymorphisms in enzymes involved in alcohol metabolism. For most chemicals, however, exposures are generally low, and efforts to study interactions between genetics and environmental factors are also hampered by lack of data on environmental exposures of interest in most datasets currently used for genomic studies.

Interpreting Findings from Studies in Animals and In Vitro Systems

Experimental studies in whole animals and in vitro systems are an essential component of research on breast cancer and of regulatory risk assessment to limit exposure to carcinogens, but the results remain approximations of human experience. In vitro systems are used to explore mechanisms by which environmental agents alter cellular and tissue behavior and to identify chemicals that cause genetic damage (genotoxic substances) in regulatory safety testing. Such systems currently do not fully account for the multiplicity of biological processes (e.g., pharmacokinetics, cell interactions) that occur in response to an exposure in a whole organism, and the degree to which they detect nongenotoxic carcinogens is uncertain. Even

Suggested Citation:"Summary." Institute of Medicine. 2012. Breast Cancer and the Environment: A Life Course Approach. Washington, DC: The National Academies Press. doi: 10.17226/13263.
×

studies in human cell lines, though they may provide useful mechanistic insights, are ill equipped to capture the full complexity of intact humans. In testing with whole animals (i.e., in vivo animal models), the small numbers of test animals make it statistically impossible to detect small increases in risk. It may also be difficult to interpret results from studies that use doses or routes of exposure that do not correspond to typical human exposures. Adding to the complexity of interpreting in vivo animal studies are differences in responses among the commonly used rat and mouse strains and assessing the significance of underlying differences in anatomy and physiology between humans and rodents.

EMPHASIZING THE LIFE COURSE IN STUDYING RISK FACTORS AND BREAST CANCER MECHANISMS

As in most types of adult cancer, breast cancer is thought to develop as a result of accumulated damage induced by both internal and external triggers resulting in initial carcinogenic events. The affected cells and tissues then progress through multiple stages, with accompanying alterations in surrounding tissue likely playing a role in permitting or potentiating the cancer process. These events contributing to subsequent cancers may occur spontaneously as a by-product of errors in normal processes, such as DNA replication, or through effects of environmental exposures, such as damage from exposure to sunlight or tobacco carcinogens; or they can be sustained and furthered by physiologic conditions, such as obesity.

The breast undergoes substantial changes from the time it begins developing in the fetus through old age, especially in response to hormonal changes during puberty, pregnancy, lactation, and menopause. The timing of a variety of environmental exposures may be important in directly increasing or reducing breast cancer risks or in acting indirectly by influencing the developmental events. There may be critical windows of susceptibility (e.g., periods of rapid cell proliferation or maturation) when specific mechanisms that increase the likelihood of a breast cancer developing may be more likely to come into play.

Research is continuing on many fronts to increase understanding of the mechanisms that contribute to breast cancer and the ways they relate to or may be modulated by exposure to environmental factors. Some exposures act principally at early stages of carcinogenesis (activating oncogenes or inactivating tumor suppressor genes within affected cells) whereas others act later (stimulating cell division and proliferation), so that mutations are less likely to be repaired and more likely to have detrimental consequences. Others may act to alter susceptibility to exposures later in life. Estrogen produced in the body is critical to normal breast development, but it also appears to play a major role in breast carcinogenesis. It may

Suggested Citation:"Summary." Institute of Medicine. 2012. Breast Cancer and the Environment: A Life Course Approach. Washington, DC: The National Academies Press. doi: 10.17226/13263.
×

do this by promoting proliferation of cells (mitogenesis) and possibly via mutagenic activity of its metabolites. Some environmental factors can have estrogenic properties, but the implications for breast cancer are not entirely clear. Environmental exposures might cause damage (mutations) to DNA; they may also act through epigenetic reprogramming, which alters gene expression without altering DNA. Factors that modify the functioning of the immune system may also contribute to carcinogenic processes. Also important may be disruption of the stromal component of the breast that normally functions to maintain the structural and functional integrity of the breast tissues through regulatory and homeostatic mechanisms.

OPPORTUNITIES FOR EVIDENCE-BASED ACTION TO REDUCE RISK OF BREAST CANCER

On average, girls born in the United States today have approximately a 12 percent risk of developing invasive breast cancer that will be diagnosed at some point in their lifetime. Among 50-year-olds, 2.4 percent of white women (or 24 out of 1,000) are likely to be diagnosed with invasive breast cancer over the next 10 years, compared with 2.2 percent of black women, 2.0 percent of Asian women, and 1.7 percent of Hispanic women. Within average values such as these, groups of women have characteristics that give them a higher or lower 10-year risk, and of course, larger risks if followed through the remainder of their lives.

Research findings that certain factors are associated with increased or decreased risk of breast cancer are typically reported in terms of measures that compare the risk in exposed and unexposed populations (i.e., relative risks, odds ratios, hazard ratios, or risk differences). In general, the environmental factors reviewed by the committee were associated with less than a doubling of risk. These findings become more meaningful when they are linked back to the actual rates of illness. Thus, a doubling of risk might mean that the 10-year risk of breast cancer is 5 percent for a group of women who have a risk factor rather than 2.5 percent for those who do not.

Finding ways to reduce risk and avert cases of breast cancer is a high priority, but at present, the evidence-based options are limited (see Chapter 6). Many of the well-known risk factors for breast cancer—older age, being female, and older age at menopause—appear to offer little or no opportunity to intervene. For a limited set of other risk factors, women have a greater opportunity to act in ways that may have the potential to reduce risk for breast cancer while carrying limited risks of increasing other adverse health outcomes (Table S-1). Some of these actions may have health benefits beyond any contribution they may make to reducing risk of breast cancer.

Suggested Citation:"Summary." Institute of Medicine. 2012. Breast Cancer and the Environment: A Life Course Approach. Washington, DC: The National Academies Press. doi: 10.17226/13263.
×

The potentially risk-reducing—but not necessarily easily accomplished—actions identified by the committee include eliminating exposure to unnecessary medical radiation throughout life; avoiding use of combination estrogen–progestin menopausal hormone therapy, unless it is considered medically appropriate and the benefits are expected to outweigh the risks; avoiding active and passive smoking; limiting alcohol consumption; increasing physical activity; and minimizing overweight and weight gain to reduce risk of postmenopausal breast cancer.

Chemoprevention using tamoxifen or raloxifene may be an appropriate choice for some women at high risk of breast cancer, but use of these medications also raises the risk of serious adverse events such as stroke and endometrial cancer. Women who qualify for use of chemoprevention should receive appropriate counseling on its benefits and risks to be able to make an informed choice.

For some of the chemicals reviewed by the committee, it may be prudent to avoid or minimize exposure because the available evidence suggests biological plausibility for exposure to be associated with an increased risk of breast cancer, or there is suggestive evidence from epidemiology, or both. The evidence is clearest for benzene, 1,3-butadiene, and ethylene oxide because there is suggestive evidence from both epidemiologic and nonhuman data. Occupational exposures to these chemicals can occur in industrial settings, and the general public is exposed through transportation-related air pollution, industrial emissions, and tobacco smoke. For cosmetics and dietary supplements, the Food and Drug Administration (FDA) can remove from the market products found to be hazardous or adulterated, but it generally lacks authority to test the safety of these products before they are sold. The committee urges efforts to better inform consumers and health professionals about the limits of FDA’s role, to encourage manufacturers to identify hormonally active ingredients in cosmetics and dietary supplements, and to ensure that FDA has effective tools to identify contaminants or ingredients that are potential contributors to increased risk of breast cancer. Similarly for chemicals in consumer products, interested organizations can help inform the public about the current provisions for testing chemicals and encourage manufacturers to improve testing and make existing information on their products more readily available.

The limited set of opportunities for individual action noted by the committee reflects the scientific community’s still incomplete understanding of which exposures might best be avoided and when, of the actions following exposure that might have a long-term benefit in reducing risk for breast cancer, and, in some cases, of the potential for unintended consequences of interventions. Few intervention studies have investigated whether factors associated with increased postmenopausal risk, such as overweight or alcohol consumption, should be avoided completely, or whether reducing or

Suggested Citation:"Summary." Institute of Medicine. 2012. Breast Cancer and the Environment: A Life Course Approach. Washington, DC: The National Academies Press. doi: 10.17226/13263.
×

TABLE S-1 Summary of Committee Assessment of Opportunities for Actions by Women That May Reduce Risk of Breast Cancer

Opportunity for Action Modification of Exposure
Personal Action Possible Requires Action by Others
Avoid inappropriate medical radiation exposurec Yes Yes
Avoid combination menopausal hormone therapy, unless medically appropriated Yes Confer with physician
Avoid or end active smoking Yes Others can facilitate
Avoid passive smoking Varies Yes
Limit or eliminate alcohol consumption Yes Others can facilitate
Maintain or increase physical activity Yes Others can facilitate
Maintain healthy weight or reduce overweight or obesity to reduce postmenopausal risk Yes Others can facilitate
Limit or eliminate workplace, consumer, and environmental exposure to chemicals that are plausible contributors to breast cancer risk while considering risks of substitutese Varies by chemical Varies
If at high risk for breast cancer, consider use of chemoprevention Yes Confer with physician

aActions to address risk factors can take various forms, some of which may be more effective than others, and some of which may have to be taken at a specific time in life to be effective. For example, increasing physical activity might be based on the amount of time spent in any one exercise opportunity, on increasing specific types of exercise, or on increasing the frequency of exercise, or perhaps some combination of any of these. Studies have not been done that provide evidence that a specific form of physical activity is optimal for reducing breast cancer risk.

bThe committee’s comments on other benefits or risks highlight major considerations, but they are not intended to be exhaustive.

cWhile recognizing the risks of ionizing radiation exposure, particularly for certain higher dose methods (e.g., computed tomography [CT] scans), it is not the committee’s intent to dissuade women from routine mammography screening, which aids in detecting early-stage tumors.

Suggested Citation:"Summary." Institute of Medicine. 2012. Breast Cancer and the Environment: A Life Course Approach. Washington, DC: The National Academies Press. doi: 10.17226/13263.
×

Action
Target Population Defined Effective Form and Timing Establisheda Other Prominent Known Risks or Benefits from Taking Actionb
All ages Yes, especially at younger ages May result in loss of clinically useful information in some instances
Likely to decrease risk for other cancers
Postmenopausal women Yes May experience moderate to severe menopausal symptoms without hormone therapy
All ages, especially before first pregnancy Yes (form)
No (timing)
Likely to reduce risk for other cancers, heart disease, stroke
All ages Yes Likely to reduce risk for other cancers, heart disease
All women Yes (form)
No (timing)
May increase risk for cardiovascular disease
No known benefit of high alcohol consumption
All ages No Likely to reduce risk for cardiovascular disease, diabetes
May increase risk for injury
Unclear No Likely to reduce risk for cardiovascular disease, diabetes, other cancers
Varies No May reduce risk for other forms of cancer or other health problems
May result in replacement with products that have health or other risks not yet identified
High-risk women Yes Depending on the agent, increased risk of endometrial cancer, stroke, deep-vein thrombosis, among others

dCombination hormone therapy with estrogen and progestin increases the risk of breast cancer, and the associated risk is reduced upon stopping therapy. Oral contraceptives are also associated with an increased risk of breast cancer while they are being used. This risk is superimposed on a low background risk for younger women, who are most likely to use oral contraceptives. Use of oral contraceptives is associated with long-term risk reduction for ovarian and endometrial cancer.

ePlausibility may be indicated by epidemiologic evidence, animal bioassays, or mechanistic studies.

Suggested Citation:"Summary." Institute of Medicine. 2012. Breast Cancer and the Environment: A Life Course Approach. Washington, DC: The National Academies Press. doi: 10.17226/13263.
×

eliminating the exposure later in adulthood will reduce the risk that might have accrued from exposure at younger ages. It is also difficult to judge what any individual woman’s change in risk might be. Moreover, much of the evidence on breast cancer risk factors has come from studies of postmenopausal breast cancer in white women, and it has pointed to a greater potential to reduce risk for estrogen receptor–positive (ER+) cancers than other types. A much better basis is needed for guidance for risk reduction for younger women and women of other races and ethnicities. Nevertheless, many of the suggested actions are likely to not only reduce breast cancer risk, but also reduce risks for other major health conditions.

DIRECTIONS FOR FUTURE RESEARCH

The research needed to better understand the relation between breast cancer risks and environmental factors ranges from further examination of elements of the biology of breast development and carcinogenesis to tests of potential interventions to reduce risk. Important components of the work recommended here are support for the research necessary to develop better tools for assessing the carcinogenicity of chemicals and pharmaceuticals as well as tools needed to strengthen epidemiologic research. The importance of a life course perspective runs throughout the recommendations.

Applying a Life Course Perspective to Studies of Breast Cancer

Progress has been made in understanding the biology of breast development and many aspects of breast cancer, but important gaps remain in understanding its causes and the extent of environmental influences on its development. Future research should increasingly focus on the influence of exposure to a variety of environmental factors during potential windows of susceptibility over the full life course, from the prenatal experience throughout adult life.

Recommendation 1: Breast cancer researchers and research funders should pursue integrated and transdisciplinary studies that provide evidence on etiologic factors and the determinants of breast cancer across the life course, with the goal of developing innovative prevention strategies that can be applied at various times in life.

These studies should seek to integrate animal models that capture the whole life course and human epidemiologic cohort studies that follow individuals over long periods of time and allow for investigation of windows of susceptibility. Long-term follow-up of cohorts is

Suggested Citation:"Summary." Institute of Medicine. 2012. Breast Cancer and the Environment: A Life Course Approach. Washington, DC: The National Academies Press. doi: 10.17226/13263.
×

critical because new, unexpected evidence frequently arises with longer follow-up.

Topics warranting attention include (but are not limited to) the biology of breast development; the mechanisms of carcinogenesis early in life, including the role of the tissue microenvironment in tumor suppression and development, and differences that may be related to tumor type; differences in effects of exposures by tumor type; the potential contribution of timing of exposure to variation in risk; and analytical tools for investigating the potential for interactions among exposures and the impact of mixtures of environmental agents on biological processes.

Other work to aid investigation of environmental influences on breast cancer risk includes

• identifying cellular, biochemical, or molecular biomarkers of early events leading to breast cancer and validating their predictive value for future risk for breast cancer;

• determining whether intermediate endpoints (e.g., indicators of breast development, peak height growth velocity) are valid and predictive biomarkers of differences in risk for breast cancer;

• investigating the role that environmental factors may have in the origins of the different types of breast cancer to better understand disparities in incidence among racial and ethnic groups;

• exploring the value of linking information across cohort studies focused on different stages of life as a way to overcome the challenges of mounting single long-term follow-up studies; and

• ensuring that cohorts established primarily to study genetic determinants of cancer and other diseases improve the capacity of these cohorts to capture information about environmental exposures over the life course.

Targeting Specific Concerns

From its examination of evidence on a selection of environmental factors, the committee sees particular benefit in further research to clarify the mechanisms underlying breast cancer.

Recommendation 2: Breast cancer researchers and research funders should pursue research to increase knowledge of mechanisms of action of environmental factors for which there is provocative, but as yet

Suggested Citation:"Summary." Institute of Medicine. 2012. Breast Cancer and the Environment: A Life Course Approach. Washington, DC: The National Academies Press. doi: 10.17226/13263.
×

inconclusive, mechanistic, animal, life course, or human health evidence of a possible association with breast cancer risk.

High-priority topics include the following:

Shift work: The biological processes and pathways through which shift work and circadian rhythm disruption relate to breast cancer; more detailed and standardized approaches to exposure assessment.

Endocrine activity: Interactions between chemicals, such as BPA, polybrominated diphenyl ethers (PBDEs), zearalenone, and certain dioxins and dioxin-like compounds, and timing of exposure, diet, and other factors that may influence the relationship of these types of compounds to breast cancer risk.

Genotoxicity: The degree to which mutagenic chemicals, such as polycyclic aromatic hydrocarbons (PAHs), benzene, and ethylene oxide, acting alone or in combination with other exposures at specific life stages, contribute to breast cancer risk at current levels of exposure.

Epigenetic activity: Fundamental research on the role of epigenetic modifications in breast cancer risk, and the potential importance of epigenetic modifications by environmental chemicals such as BPA.

Gene–environment interactions: Continued research to identify genes relevant to breast cancer that modify risk from discrete environmental exposures.

Epidemiologic Research

Studies of Occupational Cohorts and Other Highly Exposed Populations

Many known human carcinogens were first identified through studies in occupational settings where workers had chemical and physical exposures that were higher than those of the general population. With many more women in the workforce, occupational studies may now be a means to identify some exposures that increase risk for breast cancer. Other identifiable groups of women with long-term or event-related high-dose exposures may also be promising study populations.

Recommendation 3: Breast cancer researchers and research funders should pursue studies of populations with higher exposures, such as occupational cohorts, persons with event-related high exposures, or patient groups given high-dose or long-term medical treatments. These studies should include collection of information on the prevalence of known breast cancer risk factors among the study population. Sup-

Suggested Citation:"Summary." Institute of Medicine. 2012. Breast Cancer and the Environment: A Life Course Approach. Washington, DC: The National Academies Press. doi: 10.17226/13263.
×

port for these studies should include resources for the development of improved exposure assessment methods to quantify chemical and other environmental exposures potentially associated with the development of breast cancer.

New Exposure Assessment Tools

A life course perspective on breast cancer suggests that critical periods of vulnerability may exist during in utero development, in childhood, adolescence, and early adulthood, and at older ages. Exposure assessment becomes particularly challenging over such extended intervals.

Recommendation 4: Breast cancer and exposure assessment researchers and research funders should pursue research to improve methodologies for measuring, across the life course, personal exposure to and biologically effective doses of environmental factors that may alter risk for or susceptibility to breast cancer.

Such research should encompass

• improving measurements in the environment and assessing variation over time and space;

• determining routes of exposures and how they vary over time and over the life course;

• evaluating how products are used and the extent to which actual usage deviates from label instructions (e.g., home pesticide applications) as a critical component of exposure assessment, focusing on the impact on personal exposures;

• incorporating use of advanced environmental dispersion modeling techniques with accurate emissions and air monitoring data to characterize specific population exposures;

• measuring compounds and their metabolites in biospecimens, including specimens obtained by noninvasive means;

• understanding pharmacodynamics and pharmacokinetics and how they vary by life stage, body weight, nutrition, comorbidity, or other factors;

• developing other biomarkers of exposure through early biologic effects (DNA adducts, methylation, tissue changes, gene expression, etc.);

• using existing and yet-to-be-established human exposure biomonitoring programs (e.g., breast milk repositories) by geographic areas; and

• validating exposure questionnaires through various strategies.

Suggested Citation:"Summary." Institute of Medicine. 2012. Breast Cancer and the Environment: A Life Course Approach. Washington, DC: The National Academies Press. doi: 10.17226/13263.
×

Research to Advance Preventive Actions

Minimizing Exposure to Ionizing Radiation

Some of the strongest evidence reviewed by the committee supports a causal association between breast cancer and exposure to ionizing radiation. However, population exposures to ionizing radiation in medical imaging are increasing. Standards exist to ensure that mammography minimizes radiation exposures, but more needs to be learned to determine how to minimize exposures from other medical procedures.

Recommendation 5: The National Institutes of Health, the Food and Drug Administration, and the Agency for Healthcare Research and Quality should support comparative effectiveness research to assess the relative benefits and harms of imaging procedures and diagnostic/follow-up algorithms in common practice. This research effort should also assess the most effective ways to fill knowledge gaps among patients, health care providers, hospitals and medical practices, industry, and regulatory authorities regarding practices to minimize exposure to ionizing radiation incurred through medical diagnostic procedures.

Developing and Validating Interventions to Prevent Breast Cancer

Some breast cancer risk factors appear to be modifiable, but it is important to determine what modifications can be most effective in reducing risk and when during the life course these changes need to occur. For example, overweight and obesity are recognized as increasing risk for postmenopausal breast cancer, but the contribution of weight loss to reducing risk is much less clear.

Recommendation 6: Breast cancer researchers and research funders should pursue prevention research in humans and animal models to develop strategies to alter modifiable risk factors, and to test the effectiveness of these strategies in reducing breast cancer risk, including timing considerations and population subgroups likely to benefit most.

Particular aspects of prevention that require attention include

• when weight loss is most likely to be beneficial in reducing risk for postmenopausal breast cancer;

• effective strategies for achieving and maintaining weight loss in different risk groups;

• effective and sustainable methods to prevent obesity;

Suggested Citation:"Summary." Institute of Medicine. 2012. Breast Cancer and the Environment: A Life Course Approach. Washington, DC: The National Academies Press. doi: 10.17226/13263.
×

• the feasibility of interventions in early life and development that may influence breast cancer risk in adult life, such as preventing childhood obesity, increasing physical activity, and minimizing exposures to potentially harmful environmental carcinogens;

• approaches to prevention that respond to the differing breast cancer experience of various racial and ethnic groups; and

• dissemination and adoption of effective prevention strategies.

Chemoprevention—Medications to Reduce Breast Cancer Risk

Tamoxifen and raloxifene have been shown to substantially reduce risk of ER+ breast cancer in women who have not been diagnosed with the disease, and they are approved by the FDA for this use by women at increased risk of breast cancer. Other medications (e.g., aromatase inhibitors, bisphosphonates, metformin) are being studied to assess their effectiveness for reducing the risk of either ER+ or estrogen receptor–negative (ER–) breast cancer.

However, tamoxifen and raloxifene increase the risk of other potentially serious events (e.g., endometrial cancer [tamoxifen], stroke) and are not widely used. Additional research is needed to identify other drugs that can reduce risk of all forms of breast cancer with minimal risk of other adverse health effects.

Recommendation 7: Breast cancer researchers and research funders should pursue continued research into new breast cancer chemoprevention agents that have minimal risk for other adverse health effects. This work should include efforts to identify chemopreventive approaches for hormone receptor negative breast cancer.

Adequately sized primary prevention studies will be needed to allow for estimation of both benefits and risks. Research plans should also include long-term follow-up to identify any changes in risk patterns for types of breast cancer or other effects that only become evident beyond the time frame of current analyses.

Testing to Identify Potential Breast Carcinogens

In Vivo Testing for Carcinogenicity

Current whole-animal (rodent) protocols for carcinogenicity testing may not be ideally suited to screening for possible human breast carcinogens because they typically do not address changing sensitivity during the life course, such as during in utero and early postnatal periods, to

Suggested Citation:"Summary." Institute of Medicine. 2012. Breast Cancer and the Environment: A Life Course Approach. Washington, DC: The National Academies Press. doi: 10.17226/13263.
×

carcinogens or to exposures that may alter susceptibility to later carcinogenic exposures. Because of study power constraints, these tests are not usually structured to assess the low-dose exposures to mixtures that are characteristic of human experience, and interpretation of findings (positive or negative) may be complicated by the test animal strains’ characteristic susceptibility (or lack of susceptibility) to mammary tumors.

Recommendation 8: The research and testing communities should pursue a concerted and collaborative effort across a range of relevant disciplines to determine optimal whole-animal bioassay protocols for detection and evaluation of chemicals that potentially increase the risk of human breast cancer.

The development of these protocols should include consideration of the appropriateness of the rodent species and strains used for testing; the utility of genetically engineered mouse models to address specific mechanisms; the frequency, magnitude, and route of dosing that may be most relevant for predicting human risk; potential differences in sensitivity in different life stages; and standard practices for conducting studies and reporting results.

New Approaches to Toxicity Testing

New toxicity testing approaches are being developed to more rapidly and accurately screen chemicals and minimize in vivo testing. Because breast cancer is a major contributor to women’s morbidity, these tests should be relevant to the basic mechanisms of breast cancer—for example, mutagenesis, estrogen receptor signaling, epigenetic programming, modulation of immune functioning, and alterations at the whole-organ level—and to human exposures (low doses and mixtures).

Recommendation 9:

a. The research and testing communities should ensure that new testing approaches developed to serve as alternatives to long-term rodent carcinogenicity studies include components that are relevant for breast cancer. The tests should be able to account for changes in susceptibility through the life course and mechanisms characteristic of hormonally active agents. The test development should also include exploring the predictive value of in vitro and in vivo experimental testing for site-specific cancer risks for humans.

b. A research initiative should assess the persistence and consequences for mammary carcinogenicity of abnormal mammary gland development and related intermediate outcomes observed in some

Suggested Citation:"Summary." Institute of Medicine. 2012. Breast Cancer and the Environment: A Life Course Approach. Washington, DC: The National Academies Press. doi: 10.17226/13263.
×

toxicological testing. As useful predictors of increased mammary cancer risk become available, intermediate outcomes may aid in identifying chemicals that may pose increased risk of human breast cancer when exposures occur early in life.

c. Research should be conducted to improve understanding of the potential cumulative effects of multiple, small environmental exposures on risk for breast cancer and the interaction of these exposures with other factors that influence risk for breast cancer.

New Approaches to Testing Hormonally Active Candidate Pharmaceuticals

Given the evidence for hormonal influences on the development of breast cancer, the committee is concerned that testing required to gain marketing approval for various hormonally active pharmaceuticals, including oral contraceptives and menopausal hormone therapies, does not adequately address the potential for increased risk for breast cancer.

Recommendation 10: The pharmaceutical industry and other sponsors of research on new hormonally active pharmaceutical products should support the development and validation of better preclinical screening tests that can be used before such products are brought to market to help evaluate their potential for increasing the risk of breast cancer.

A suite of in vitro and in vivo tests will likely be needed to address the different mechanisms of action that may be relevant over the life course. If such tests can be developed and validated, FDA should require submission of the results as part of the process for approving the introduction of new hormonal preparations for prescription or over-the-counter use. These tests may also prove useful in testing environmental chemicals.

Postmarketing Studies of Hormonally Active Drugs

With the demonstration that use of certain hormonally active prescription drugs is associated with an increased risk of breast cancer and other adverse health effects, it is important to investigate whether use of other hormonally active drugs is also associated with increased risk.

Recommendation 11: FDA should use its authority under the Food and Drug Administration Amendments Act of 2007 to engage the pharmaceutical industry and scientific community in postmarketing studies or clinical trials for hormonally active prescription drugs for which the potential impact on breast cancer risk has not been well characterized.

Suggested Citation:"Summary." Institute of Medicine. 2012. Breast Cancer and the Environment: A Life Course Approach. Washington, DC: The National Academies Press. doi: 10.17226/13263.
×

The studies should be adequately powered to quantitatively explore the possible contribution of the products to breast cancer risk. Products that represent a substantial change in pharmacologic composition or dosage schedule from products currently on the market should be a particular focus of attention.

Understanding Breast Cancer Risks

Researchers, health care providers, and the public all have an incomplete picture of the components of breast cancer risk. Further work is needed to clarify the contribution of recognized risk factors to differences and changes in the incidence of breast cancer and to determine the most effective ways to convey information about breast cancer risk.

Risk Modeling

Systematic modeling approaches are needed to refine estimates of the proportion of breast cancer in the United States and other countries that can be attributed to established risk factors (individually and in combination), especially those that can be modified. Additionally, better data are needed on the prevalence of these risk factors. Improved estimates of risk associated with established factors should help in determining the scale of residual risk, which may be associated with other environmental exposures. A collaborative approach, such as that used by the Cancer Intervention and Surveillance Modeling Network (CISNET) consortium, may be a cost-effective way to pursue this work.

Recommendation 12: Breast cancer researchers and research funders should pursue efforts to (1) develop statistical methodology for the estimation of risk of breast cancer for given sets of risk factors and that takes the life course perspective into account, (2) determine the proportion of the total temporal and geographic differences in breast cancer rates that can be plausibly attributed to established risk factors, and (3) develop modeling tools that allow for calculation of breast cancer risk, in both absolute and relative terms, with the goal of assessing potential risk reduction strategies at both personal and public health levels.

Communicating About Breast Cancer Risks

Accurate and effective communication of breast cancer risks is challenging, and developing better approaches should be a research target. Uncertainty is inherent in risk prediction, but it is important to inform a broad range of stakeholders and constituencies on both those exposures

Suggested Citation:"Summary." Institute of Medicine. 2012. Breast Cancer and the Environment: A Life Course Approach. Washington, DC: The National Academies Press. doi: 10.17226/13263.
×

that are associated with increased risk and those that have no evident association with breast cancer.

Recommendation 13: Breast cancer researchers and research funders should pursue research to identify the most effective ways of communicating accurate breast cancer risk information and statistics to the general public, health care professionals, and policy makers.

This work should include identifying ways to improve translation of research results into messages that can effectively convey the implications for women in different risk categories, women from diverse racial and ethnic groups, health care providers, and public health decision makers. It also should include ways to convey information about chemicals for which there is suggestive evidence of risk from experimental studies.

CONCLUDING OBSERVATIONS

Breast cancer is a leading cause of cancer morbidity among women in the United States and many other countries. Major advances have been made in understanding its biology and diversity, but more needs to be learned about the causes of breast cancer and how to prevent it. Familiar advice about healthful lifestyles appears relevant, but it remains difficult to discern what contribution a diverse array of other environmental factors may be making. Important targets for research are the biologic significance of life stages at which environmental risk factors are encountered, what steps may counter their effects, when preventive actions can be most effective, and whether opportunities for prevention can be found for the variety of forms of breast cancer.

Suggested Citation:"Summary." Institute of Medicine. 2012. Breast Cancer and the Environment: A Life Course Approach. Washington, DC: The National Academies Press. doi: 10.17226/13263.
×

This page intentionally left blank.

Suggested Citation:"Summary." Institute of Medicine. 2012. Breast Cancer and the Environment: A Life Course Approach. Washington, DC: The National Academies Press. doi: 10.17226/13263.
×
Page1
Suggested Citation:"Summary." Institute of Medicine. 2012. Breast Cancer and the Environment: A Life Course Approach. Washington, DC: The National Academies Press. doi: 10.17226/13263.
×
Page2
Suggested Citation:"Summary." Institute of Medicine. 2012. Breast Cancer and the Environment: A Life Course Approach. Washington, DC: The National Academies Press. doi: 10.17226/13263.
×
Page3
Suggested Citation:"Summary." Institute of Medicine. 2012. Breast Cancer and the Environment: A Life Course Approach. Washington, DC: The National Academies Press. doi: 10.17226/13263.
×
Page4
Suggested Citation:"Summary." Institute of Medicine. 2012. Breast Cancer and the Environment: A Life Course Approach. Washington, DC: The National Academies Press. doi: 10.17226/13263.
×
Page5
Suggested Citation:"Summary." Institute of Medicine. 2012. Breast Cancer and the Environment: A Life Course Approach. Washington, DC: The National Academies Press. doi: 10.17226/13263.
×
Page6
Suggested Citation:"Summary." Institute of Medicine. 2012. Breast Cancer and the Environment: A Life Course Approach. Washington, DC: The National Academies Press. doi: 10.17226/13263.
×
Page7
Suggested Citation:"Summary." Institute of Medicine. 2012. Breast Cancer and the Environment: A Life Course Approach. Washington, DC: The National Academies Press. doi: 10.17226/13263.
×
Page8
Suggested Citation:"Summary." Institute of Medicine. 2012. Breast Cancer and the Environment: A Life Course Approach. Washington, DC: The National Academies Press. doi: 10.17226/13263.
×
Page9
Suggested Citation:"Summary." Institute of Medicine. 2012. Breast Cancer and the Environment: A Life Course Approach. Washington, DC: The National Academies Press. doi: 10.17226/13263.
×
Page10
Suggested Citation:"Summary." Institute of Medicine. 2012. Breast Cancer and the Environment: A Life Course Approach. Washington, DC: The National Academies Press. doi: 10.17226/13263.
×
Page11
Suggested Citation:"Summary." Institute of Medicine. 2012. Breast Cancer and the Environment: A Life Course Approach. Washington, DC: The National Academies Press. doi: 10.17226/13263.
×
Page12
Suggested Citation:"Summary." Institute of Medicine. 2012. Breast Cancer and the Environment: A Life Course Approach. Washington, DC: The National Academies Press. doi: 10.17226/13263.
×
Page13
Suggested Citation:"Summary." Institute of Medicine. 2012. Breast Cancer and the Environment: A Life Course Approach. Washington, DC: The National Academies Press. doi: 10.17226/13263.
×
Page14
Suggested Citation:"Summary." Institute of Medicine. 2012. Breast Cancer and the Environment: A Life Course Approach. Washington, DC: The National Academies Press. doi: 10.17226/13263.
×
Page15
Suggested Citation:"Summary." Institute of Medicine. 2012. Breast Cancer and the Environment: A Life Course Approach. Washington, DC: The National Academies Press. doi: 10.17226/13263.
×
Page16
Suggested Citation:"Summary." Institute of Medicine. 2012. Breast Cancer and the Environment: A Life Course Approach. Washington, DC: The National Academies Press. doi: 10.17226/13263.
×
Page17
Suggested Citation:"Summary." Institute of Medicine. 2012. Breast Cancer and the Environment: A Life Course Approach. Washington, DC: The National Academies Press. doi: 10.17226/13263.
×
Page18
Suggested Citation:"Summary." Institute of Medicine. 2012. Breast Cancer and the Environment: A Life Course Approach. Washington, DC: The National Academies Press. doi: 10.17226/13263.
×
Page19
Suggested Citation:"Summary." Institute of Medicine. 2012. Breast Cancer and the Environment: A Life Course Approach. Washington, DC: The National Academies Press. doi: 10.17226/13263.
×
Page20
Suggested Citation:"Summary." Institute of Medicine. 2012. Breast Cancer and the Environment: A Life Course Approach. Washington, DC: The National Academies Press. doi: 10.17226/13263.
×
Page21
Suggested Citation:"Summary." Institute of Medicine. 2012. Breast Cancer and the Environment: A Life Course Approach. Washington, DC: The National Academies Press. doi: 10.17226/13263.
×
Page22
Suggested Citation:"Summary." Institute of Medicine. 2012. Breast Cancer and the Environment: A Life Course Approach. Washington, DC: The National Academies Press. doi: 10.17226/13263.
×
Page23
Suggested Citation:"Summary." Institute of Medicine. 2012. Breast Cancer and the Environment: A Life Course Approach. Washington, DC: The National Academies Press. doi: 10.17226/13263.
×
Page24
Next: 1 Introduction »
Breast Cancer and the Environment: A Life Course Approach Get This Book
×
Buy Paperback | $75.00 Buy Ebook | $59.99
MyNAP members save 10% online.
Login or Register to save!
Download Free PDF

Breast cancer remains the most common invasive cancer among women. The primary patients of breast cancer are adult women who are approaching or have reached menopause; 90 percent of new cases in U.S. women in 2009 were diagnosed at age 45 or older. Growing knowledge of the complexity of breast cancer stimulated a transition in breast cancer research toward elucidating how external factors may influence the etiology of breast cancer.

Breast Cancer and the Environment reviews the current evidence on a selection of environmental risk factors for breast cancer, considers gene-environment interactions in breast cancer, and explores evidence-based actions that might reduce the risk of breast cancer. The book also recommends further integrative research into the elements of the biology of breast development and carcinogenesis, including the influence of exposure to a variety of environmental factors during potential windows of susceptibility during the full life course, potential interventions to reduce risk, and better tools for assessing the carcinogenicity of environmental factors. For a limited set of risk factors, evidence suggests that action can be taken in ways that may reduce risk for breast cancer for many women: avoiding unnecessary medical radiation throughout life, avoiding the use of some forms of postmenopausal hormone therapy, avoiding smoking, limiting alcohol consumption, increasing physical activity, and minimizing weight gain.

Breast Cancer and the Environment sets a direction and a focus for future research efforts. The book will be of special interest to medical researchers, patient advocacy groups, and public health professionals.

  1. ×

    Welcome to OpenBook!

    You're looking at OpenBook, NAP.edu's online reading room since 1999. Based on feedback from you, our users, we've made some improvements that make it easier than ever to read thousands of publications on our website.

    Do you want to take a quick tour of the OpenBook's features?

    No Thanks Take a Tour »
  2. ×

    Show this book's table of contents, where you can jump to any chapter by name.

    « Back Next »
  3. ×

    ...or use these buttons to go back to the previous chapter or skip to the next one.

    « Back Next »
  4. ×

    Jump up to the previous page or down to the next one. Also, you can type in a page number and press Enter to go directly to that page in the book.

    « Back Next »
  5. ×

    Switch between the Original Pages, where you can read the report as it appeared in print, and Text Pages for the web version, where you can highlight and search the text.

    « Back Next »
  6. ×

    To search the entire text of this book, type in your search term here and press Enter.

    « Back Next »
  7. ×

    Share a link to this book page on your preferred social network or via email.

    « Back Next »
  8. ×

    View our suggested citation for this chapter.

    « Back Next »
  9. ×

    Ready to take your reading offline? Click here to buy this book in print or download it as a free PDF, if available.

    « Back Next »
Stay Connected!